全文获取类型
收费全文 | 115718篇 |
免费 | 10476篇 |
国内免费 | 250篇 |
专业分类
耳鼻咽喉 | 1664篇 |
儿科学 | 3293篇 |
妇产科学 | 2258篇 |
基础医学 | 15831篇 |
口腔科学 | 2441篇 |
临床医学 | 13779篇 |
内科学 | 21408篇 |
皮肤病学 | 1696篇 |
神经病学 | 9622篇 |
特种医学 | 4075篇 |
外国民族医学 | 10篇 |
外科学 | 16933篇 |
综合类 | 2040篇 |
一般理论 | 107篇 |
预防医学 | 12468篇 |
眼科学 | 2361篇 |
药学 | 9210篇 |
1篇 | |
中国医学 | 107篇 |
肿瘤学 | 7140篇 |
出版年
2022年 | 1003篇 |
2021年 | 2173篇 |
2020年 | 1350篇 |
2019年 | 2074篇 |
2018年 | 2530篇 |
2017年 | 1794篇 |
2016年 | 1900篇 |
2015年 | 2196篇 |
2014年 | 3066篇 |
2013年 | 4440篇 |
2012年 | 6184篇 |
2011年 | 6523篇 |
2010年 | 3439篇 |
2009年 | 3251篇 |
2008年 | 5534篇 |
2007年 | 5818篇 |
2006年 | 5500篇 |
2005年 | 5573篇 |
2004年 | 5217篇 |
2003年 | 4787篇 |
2002年 | 4586篇 |
2001年 | 2895篇 |
2000年 | 2988篇 |
1999年 | 2714篇 |
1998年 | 1362篇 |
1997年 | 1107篇 |
1996年 | 1093篇 |
1995年 | 933篇 |
1994年 | 964篇 |
1993年 | 871篇 |
1992年 | 2176篇 |
1991年 | 2093篇 |
1990年 | 1959篇 |
1989年 | 1917篇 |
1988年 | 1823篇 |
1987年 | 1817篇 |
1986年 | 1711篇 |
1985年 | 1698篇 |
1984年 | 1438篇 |
1983年 | 1309篇 |
1982年 | 905篇 |
1981年 | 757篇 |
1979年 | 1233篇 |
1978年 | 891篇 |
1977年 | 775篇 |
1976年 | 726篇 |
1975年 | 726篇 |
1974年 | 867篇 |
1973年 | 758篇 |
1972年 | 739篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献32.
Louise A. Rollins-Smith J. Scott Fites Laura K. Reinert Andrea R. Shiakolas Thomas P. Umile Kevin P. C. Minbiole 《Infection and immunity》2015,83(12):4565-4570
Batrachochytrium dendrobatidis is a fungal pathogen in the phylum Chytridiomycota that causes the skin disease chytridiomycosis. Chytridiomycosis is considered an emerging infectious disease linked to worldwide amphibian declines and extinctions. Although amphibians have well-developed immune defenses, clearance of this pathogen from the skin is often impaired. Previously, we showed that the adaptive immune system is involved in the control of the pathogen, but B. dendrobatidis releases factors that inhibit in vitro and in vivo lymphocyte responses and induce lymphocyte apoptosis. Little is known about the nature of the inhibitory factors released by this fungus. Here, we describe the isolation and characterization of three fungal metabolites produced by B. dendrobatidis but not by the closely related nonpathogenic chytrid Homolaphlyctis polyrhiza. These metabolites are methylthioadenosine (MTA), tryptophan, and an oxidized product of tryptophan, kynurenine (Kyn). Independently, both MTA and Kyn inhibit the survival and proliferation of amphibian lymphocytes and the Jurkat human T cell leukemia cell line. However, working together, they become effective at much lower concentrations. We hypothesize that B. dendrobatidis can adapt its metabolism to release products that alter the local environment in the skin to inhibit immunity and enhance the survival of the pathogen. 相似文献
33.
34.
35.
36.
ABSTRACTTake-Away Points:1. Geriatric palliative care requires integrating the disciplines of hospital medicine and palliative care in pursuit of delivering comprehensive, whole-person care to aging patients with serious illnesses.2. Older adults have unique palliative care needs compared to the general population, different prevalence and intensity of symptoms, more frequent neuropsychiatric challenges, increased social needs, distinct spiritual, religious, and cultural considerations, and complex medicolegal and ethical issues.3. Hospital-based palliative care interdisciplinary teams can take many forms and provide high-quality, goal-concordant care to older adults and their families. 相似文献
37.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
38.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献39.
40.